Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance EA Pietilä, J Gonzalez-Molina, L Moyano-Galceran, S Jamalzadeh, ... Nature communications 12 (1), 3904, 2021 | 84 | 2021 |
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study MM Etter, TA Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ... Nature communications 13 (1), 6777, 2022 | 39 | 2022 |
Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery T Shekarian, CP Zinner, EM Bartoszek, W Duchemin, AT Wachnowicz, ... Science Advances 8 (26), eabn9440, 2022 | 23 | 2022 |
Microglia-centered combinatorial strategies against glioblastoma TA Martins, P Schmassmann, T Shekarian, JL Boulay, MF Ritz, ... Frontiers in immunology 11, 571951, 2020 | 18 | 2020 |
Targeting the Siglec–Sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma P Schmassmann, J Roux, A Buck, N Tatari, S Hogan, J Wang, ... Science translational medicine 15 (705), eadf5302, 2023 | 7 | 2023 |
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: A prospective cross-sectional study MM Etter, T A. Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ... medRxiv, 2022.02. 18.22271039, 2022 | 3 | 2022 |
Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation P Schmassmann, J Roux, S Dettling, S Hogan, T Shekarian, TA Martins, ... Elife 12, RP92678, 2023 | 2 | 2023 |
ENHANCING GLIOBLASTOMA CLEARANCE: EMPOWERING ANTI-EGFRVIII CAR T CELLS WITH A PARACRINE SIRPGamma-DERIVED CD47 BLOCKER T Martins, N Tatari, D Kaymak, EM Bartoszek, S Hogan, A Buck, MF Ritz, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker TA Martins, N Tatari, D Kaymak, S Hogan, EM Bartoszek, R Wieboldt, ... bioRxiv, 2023.08. 31.555122, 2023 | | 2023 |
Multidimensional analysis of matched primary and recurrent glioblastoma identifies Fcgamma receptors upregulation on microglia as a contributor of tumor recurrence. T Shekarian, S Hogan, TA Martins, P Schmassmann, A Gerber, J Roux, ... bioRxiv, 2023.04. 21.537308, 2023 | | 2023 |
Angiopoietin 1 and integrin beta 1b are vital for zebrafish brain development YC Chen, TA Martins, V Marchica, P Panula Frontiers in Cellular Neuroscience 17, 2023 | | 2023 |
The Siglec-sialic acid-axis is a target for innate immunotherapy of glioblastoma P Schmassmann, J Roux, A Buck, N Tatari, S Hogan, J Wang, S Lee, ... bioRxiv, 2022.11. 07.515406, 2022 | | 2022 |
TMIC-77. SINGLE-CELL CHARACTERIZATION OF HUMAN GBM REVEALS REGIONAL DIFFERENCES IN TUMOR-INFILTRATING LEUKOCYTE ACTIVATION P Schmassmann, J Roux, S Dettling, S Hogan, T Shekarian, TA Martins, ... Neuro-Oncology 24 (Suppl 7), vii288, 2022 | | 2022 |
HUMANIN RELEASE FROM TUMOR ASSOCIATED MYELOID CELLS PROMOTES GLIOMA CHEMORESISTANCE P Schmassmann, J Roux, S Dettling, S Hogan, T Shekarian, TA Martins, ... NEURO-ONCOLOGY 24, 288-288, 2022 | | 2022 |
P06. 03. A Combination of EGFRvIII CAR T cell therapy and paracrine GAM modulation for the treatment of GBM TA Martins, N Tatari, M Ritz, T Shekarian, P Schmassmann, D Kaymak, ... Neuro-Oncology 24 (Suppl 2), ii38, 2022 | | 2022 |
P17. 10. B Identification of mechanisms involved in the recurrence of glioblastoma by transcriptomic, proteomic and spatial profiling analysis M Ritz, T Shekarian, T Martins, S Hogan, P Schmassmann, B Burger, ... Neuro-Oncology 24 (Suppl 2), ii91, 2022 | | 2022 |
IMMU-40. IMMUNE PROFILING OF MATCHED PRIMARY AND RECURRENT GLIOBLASTOMA TUMORS IDENTIFIED CD64 AS A NEGATIVE PREDICTOR FOR SURVIVAL T Shekarian, MF Ritz, T Martins, P Schmassmann, G Hutter Neuro-Oncology 23 (Supplement_6), vi101-vi101, 2021 | | 2021 |
COMBINATION OF EGFRVIII CAR T-CELL THERAPY AND PARACRINE GAM MODULATION FOR THE TREATMENT OF GBM TA Martins, MF Ritz, T Shekarian, P Schmassmann, D Kaymak, V Bicvic, ... NEURO-ONCOLOGY 23, 102-103, 2021 | | 2021 |
THE IMPACT OF MICROGLIA MODULATION ON GBM PROGRESSION IN SYNGENEIC MOUSE MODELS MF Ritz, T Shekarian, TA Martins, P Schmassmann, G Hutter NEURO-ONCOLOGY 23, 96-96, 2021 | | 2021 |
EXTH-45. MICROGLIA-SPECIFIC DISRUPTION OF SIALIC ACID-SIGLEC-9/E INTERACTIONS: A NOVEL IMMUNOTHERAPY AGAINST GLIOBLASTOMA? P Schmassmann, TA Martins, M Stanczak, MF Ritz, T Shekarian, ... Neuro-Oncology 23 (Suppl 6), vi173, 2021 | | 2021 |